Open access · OA
via OpenAlex
Therapeutic approaches to Alzheimer's disease
Hans‐Wolfgang Klafki, Matthias Staufenbiel, Johannes Kornhuber, Jens Wiltfang
Brain · 2006 · ▲ 362 citations
Abstract
Alzheimer's disease is an age-related progressive neurodegenerative disorder with an enormous unmet medical need. It is the most common form of dementia affecting approximately 5% of adults over 65 years. In view of our ageing society the number of patients, as well as the economical and social impact, is expected to grow dramatically in the future. Currently available medications appear to be able to produce moderate symptomatic benefits but not to stop disease progression. The search for novel therapeutic approaches targeting the presumed underlying pathogenic mechanisms has been a major focus of research and it is expected that novel medications with disease-modifying properties will emerge from these efforts in the future. In this review, currently available drugs as well as novel therapeutic strategies, in particular those targeting amyloid and tau pathologies, are discussed.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/brain/awl280
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Klafki, H., Staufenbiel, M., Kornhuber, J., & Wiltfang, J. (2006). Therapeutic approaches to Alzheimer's disease. <em>Brain</em>. https://doi.org/10.1093/brain/awl280
Vancouver
Klafki H, Staufenbiel M, Kornhuber J, Wiltfang J. Therapeutic approaches to Alzheimer's disease. Brain. 2006. doi:10.1093/brain/awl280.
BibTeX
@article{hanswolfgang2006Therap,
title = {Therapeutic approaches to Alzheimer's disease},
author = {Hans‐Wolfgang Klafki and Matthias Staufenbiel and Johannes Kornhuber and Jens Wiltfang},
journal = {Brain},
year = {2006},
doi = {10.1093/brain/awl280},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Pharmacology 2020
Open access · CC-BY
Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease
Chang Gung Memorial Hospital 2019
Open access · US-GOV
Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18F-florbetapir (AV-45) PET Examination
Cells 2022
Open access · CC-BY
Alpha-Synuclein Aggregation Pathway in Parkinson’s Disease: Current Status and Novel Therapeutic Approaches
Genes & Development 2010
Open access · OA
Molecular genetics of prostate cancer: new prospects for old challenges
Thorax 2017
Open access · OA
GDF11: a fountain of youth for the ageing COPD lung?
Molecular Neurodegeneration 2020
Open access · CC-BY